首页> 外文期刊>Behavioural Brain Research: An International Journal >Liquiritigenin reverses depression-like behavior in unpredictable chronic mild stress-induced mice by regulating PI3K/Akt/mTOR mediated BDNF/TrkB pathway
【24h】

Liquiritigenin reverses depression-like behavior in unpredictable chronic mild stress-induced mice by regulating PI3K/Akt/mTOR mediated BDNF/TrkB pathway

机译:Liquiritigenin通过调节PI3K / Akt / mTOR介导的BDNF / TrkB途径逆转不可预测的慢性轻度应激诱导的小鼠的抑郁样行为

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Major depression is a common long-lasting or recurrent psychiatric disease with high lifetime prevalence and high incidence of suicide. The main purpose of the current study was to verify whether liquiritigenin conferred an antidepressant-like effect on the depressive mouse model established by unpredictable chronic mild stress (UCMS) and explore its possible mechanism. The results of depression related behaviors including sucrose preference test (SPT), open field test (OFT), forced swimming test (FST) and tail suspension test (TST) indicated that both liquiritigenin (7.5 mg/kg, 15 mg/kg) and fluoxetine (20 mg/kg) dramatically improved the depression symptoms. Enzyme-linked immunosorbent assay (ELISA) revealed that treatment with liquiritigenin significantly reduced the concentrations of pro inflammatory cytokines including interleukin (IL)-6, IL-1 beta and tumor necrosis factor (TNF)-alpha in serum and hippocampus. Compared with the UCMS group, the administrations of liquiritigenin, increased levels of superoxide dismutase (SOD), glutathione (GSH), catalase (CAT), and decreased Malondialdehyde (MDA) content. Meanwhile, glucocorticoids (GC) content was reduced in the liquiritigenin group, which suggested that liquiritigenin exhibiting the ameliorative effect on activated hypothalamic-pituitary-adrenal (HPA) axis stimulated with UCMS. Mice treated with liquiritigenin showed restored levels of neurotransmitter norepinephrine (NE) and serotonin (5-HT). Western blot analysis displayed up-regulated expressions of p-phosphatidylinositol 3-kinase (PI3 K), p-Akt, p-mammalian target of rapamycin (mTOR), p-tropomyosin-related kinase B (TrkB), brain-derived neurotrophic factor (BDNF). Thus, it was supposed that liquiritigenin might be useful for the treatment of chronic depression possibly through PI3 K/Akt/mTOR mediated BDNF/TrkB pathway. (C) 2016 Elsevier B.V. All rights reserved.
机译:重度抑郁症是一种常见的长期或复发性精神病,终生患病率高,自杀率高。这项研究的主要目的是验证是否liquiritigenin对不可预测的慢性轻度应激(UCMS)建立的抑郁症小鼠模型具有抗抑郁样作用,并探讨其可能的机制。抑郁相关行为的结果包括蔗糖偏爱测试(SPT),开阔视野测试(OFT),强迫游泳测试(FST)和尾部悬吊测试(TST)表明,两种脂蛋白素(7.5 mg / kg,15 mg / kg)和氟西汀(20 mg / kg)可显着改善抑郁症状。酶联免疫吸附试验(ELISA)显示,用liquiritigenin处理可显着降低血清和海马中促炎细胞因子的浓度,包括白介素(IL)-6,IL-1β和肿瘤坏死因子(TNF)-α。与UCMS组相比,liquiritigenin的给药,超氧化物歧化酶(SOD),谷胱甘肽(GSH),过氧化氢酶(CAT)的水平升高和丙二醛(MDA)含量降低。同时,liquiritigenin组的糖皮质激素(GC)含量降低,这表明liquiritigenin对UCMS刺激的激活的下丘脑-垂体-肾上腺(HPA)轴具有缓解作用。接受liquiritigenin处理的小鼠神经递质去甲肾上腺素(NE)和血清素(5-HT)的水平恢复了。 Western印迹分析显示上调了p-磷脂酰肌醇3-激酶(PI3 K),p-Akt,雷帕霉素的p-哺乳动物靶标(mTOR),p-原肌球蛋白相关激酶B(TrkB),脑源性神经营养因子的表达(BDNF)。因此,据推测,liquiritigenin可能通过PI3K / Akt / mTOR介导的BDNF / TrkB途径可用于治疗慢性抑郁症。 (C)2016 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号